FDA’s cannabis policy, proposed by the agency this week, would allow doctors to prescribe cannabis-based medicines that contain THC, a psychoactive compound found in cannabis.
The move would allow physicians to prescribe THC-based medical products for patients suffering from the effects of the drug.
Medical cannabis is already legal in 19 states and Washington, D.C. but is still illegal under federal law.
The DEA’s proposal to create a new classification for medical cannabis would allow it to be prescribed by doctors.
In fact, doctors would be allowed to prescribe it on a case-by-case basis, according to the FDA.
Medical marijuana has been widely used in the United States since the early 2000s and there are now more than 200,000 people with a valid medical marijuana license in the country.
Doctors can prescribe cannabis for certain conditions, such as chronic pain, nausea, and other medical conditions.
But doctors can’t prescribe cannabis without a doctor’s recommendation.
“Doctors have long relied on patients to make informed, informed decisions about their medical treatment.
By creating a new, separate medical condition for which they are authorized, this proposal would provide them with additional flexibility to provide cannabis for their patients,” the FDA said in a statement.
“The new medical condition could also be used by doctors to address the pain and suffering of patients in other conditions.
And this would allow them to provide patients with options for accessing and using medical cannabis if a patient requires it.”
Doctors could also use cannabis to treat patients with conditions that are curable or treat symptoms that are treatable with traditional medicines.
A physician would be able to write a prescription to a doctor who has the authorization to prescribe the medical cannabis, according the FDA, as well as to a registered caregiver who is authorized to administer it.
The new classification would also allow physicians who have a doctor-prescribed prescription for cannabis to dispense it, even if the patient is not in the US.
This would help the medical marijuana community.
“It will enable patients to continue using cannabis to alleviate their pain and other conditions, as long as they are receiving medical care in the U.S.,” said Dr. Stephen Smith, executive director of the Medical Marijuana Policy Project, in a press release.
“This could be a huge step forward for patients and for patients’ rights.
We hope the FDA will make good on its promise to protect patients from unnecessary restrictions on their right to safely and effectively access this life-saving medicine.”
The new policy would also provide the federal government with a list of qualifying conditions for which doctors are authorized to prescribe medical cannabis.
This list would include “cancer, HIV, inflammatory bowel disease, arthritis, PTSD, seizure disorders, and seizure disorders associated with other debilitating illnesses.”
It would also include conditions that can be controlled with medication or surgery.
Currently, patients who are suffering from a condition that is curable with conventional medicines and suffering from severe pain can only receive a prescription for a prescription that includes THC.
A prescription for an additional medicine would need to include CBD, which has similar effects.
The FDA proposal will likely be challenged in court.
The Trump administration has been criticized for its recent efforts to restrict cannabis, including its recent proposal to block all state laws regulating the substance.
This includes a move to rescind the DEA’s approval of cannabidiol oil, which contains CBD.
The federal government is also taking a hard stance on cannabis legalization in states such as California and Colorado, where voters have approved initiatives that would allow recreational use of cannabis.